THE DANGERS OF PLAYING TO TRUMP'S NEEDINESS By Jennifer

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks
184
Quote:
THE DANGERS OF PLAYING TO TRUMP'S NEEDINESS
By Jennifer Rubin


March 29 at 9:00 AM

President Trump’s constant need for affirmation prompts him to exaggerate or lie about everything from his wealth to the economy to his North Korea diplomacy to the results of Robert S. Mueller III’ Russia report. The thirst to be the richest, the greatest diplomat and the exonerated victim compels him and his apologists to seek temporary applause from their base at the expense of later revelations that disprove his claimed accomplishment and reaffirm his compulsion to lie.

The Post reports, for example, that Michael Cohen, his former lawyer, may have been on to something when he accused Trump of lying about his wealth for financial benefit:

When Donald Trump wanted to make a good impression — on a lender, a business partner, or a journalist — he sometimes sent them official-looking documents called “Statements of Financial Condition.”

These documents sometimes ran up to 20 pages. They were full of numbers, laying out Trump’s properties, debts and multibillion-dollar net worth.

But, for someone trying to get a true picture of Trump’s net worth, the documents were deeply flawed. Some simply omitted properties that carried big debts. Some assets were overvalued. And some key numbers were wrong.

Trump’s allegedly misleading financial claims may or may not be illegal; but they confirm the portrait of him as a cheat, the epitome of the big guy who tries to break the rules little guys must follow. In the worst-case scenario either state prosecutors or federal prosecutors from the Southern District of New York will find criminality. At the least, expect Democrats to push ethics reform and argue Trump represents the worst of Washington (and New York) corruption.

Trump also exaggerates his own economic success. How long has he been claiming to have presided over the best economy ever, the biggest growth ever? How many times did he promise his tax plan would bring more than 3 percent GDP growth for the foreseeable future? Well eventually the numbers come out.

For all the big talk and trillions of dollars in tax cuts, Trump didn’t even clear 3 percent GDP growth in 2018. We may be going downhill from there. Trump’s exaggerated claims raised expectations that he could never meet. Now, and in 2020, he’ll have to pay the price if the economy slows. Then he would look not only incompetent but deceitful.

In the case of North Korea, Trump and his boot-licking secretary of state have continued to insist that Trump has made progress in getting North Korea to denuclearize. It turned out to be false after the first summit, and false again after the second. All Trump has done is suspend military exercises with South Korea, tried to nix sanctions and given Kim Jong Un two huge PR triumphs. Now, Secretary of State Mike Pompeo -- like his boss -- won’t even say Kim is responsible for human rights horrors. This is appeasement of the worst kind, the sort of thing Republicans would have vilified President Obama for trying.

Then there’s the Mueller report. What a swell idea -- get Attorney General William Barr to defeat the entire purpose of a special counsel by weighing in to exonerate the president of any wrongdoing and to provide a scant summary of hundreds of pages of evidence! Well, most voters long ago learned not to buy his spin so the polls don’t show most voters think he has been exonerated. What’s more, when hundreds and hundreds of pages come out recounting all the Russian contacts with Trump campaign members, the false conspiracy theories, the efforts to interfere with the investigation and the uncontroverted evidence Russia helped Trump get reelected, Trump and Barr may well look like they tried to cover up an investigation into a coverup.

The New York Times explains:

The total of 300-plus pages suggests that Mr. Mueller went well beyond the kind of bare-bones summary required by the Justice Department regulation governing his appointment and detailed his conclusions at length. And it raises questions about what Mr. Barr might have left out of the four dense pages he sent Congress.

Democrats, who like all other lawmakers have not seen the report, have all but accused Mr. Barr of covering up damaging information it contains. They have specifically focused on an apparent difference between the views of Mr. Barr and Mr. Mueller on whether Mr. Trump obstructed justice. Democrats have demanded that the attorney general make the full report and evidence public.

And if Barr doesn’t provide the entire report, cries of “coverup!” will intensify. (“Mr. Mueller probably collected and generated hundreds of thousands if not millions of pages of paper in his investigation. Congress has made clear it would eventually like access to all of them, but the Justice Department could have good reason to block some of their release, leaving it once again to the courts to determine who sees what.”)

After the short-term relief and “Mission Accomplished" celebration, they will soon have to deal with facts -- lots of them that as Mueller said, do NOT exonerate Trump of obstruction and reflect evidence that, while perhaps not criminal (at least not indictable for a sitting president), confirm much of the reporting of misconduct, disloyalty to the United States and lying.

Trump’s neediness feeds an endless cycle of exaggeration and lying, revelation and underperformance. Indeed, that’s pretty much the story of Trump’s life -- the snake oil salesmen doesn’t really have the goods.
-washingtonpost.com
https://www.washingtonpost.com/opinions/2019/...405e3e0ca4
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Rigel Pharmaceuticals Updates on Financials and Future Plans

Updated Category News Views 130

Rigel Pharmaceuticals' Business Update and 2025 Outlook Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a notable biotechnology company, recently provided a compelling business update, highlighting its financial performance and strategic ambitions for 2025. The report shared preliminary insights into the fourth quarter of 2024, showcasing substantial revenue streams from its...

Continue Reading
Grant Cardone Explores Future of Investments in Bitcoin and Real Estate

Updated Category News Views 409

Understanding Investment Shifts in Today's Economy Grant Cardone, a prominent real estate investor and entrepreneur known for his work with Cardone Capital, is keeping a keen eye on the fluctuations within the investment landscape. With approximately $7 trillion currently held in money markets, he questions where this substantial amount of cash will be allocated as...

Continue Reading
BlueNord ASA Secures Major Funding Through Hybrid Bond Issuance

Updated Category News Views 175

BlueNord ASA Successfully Places Hybrid Bond Issue BlueNord ASA (OSE: BNOR) has achieved a significant milestone in its financial strategy with the successful placement of a new subordinated callable hybrid bond issue worth USD 300 million. This bond matures in 2085, marking a robust step forward for the company. The first call on the hybrid bond is at 100% of nominal...

Continue Reading
Aehr Test Systems (NASDAQ: AEHR) Sees Growth in 2026 Amid Fluctuations

Updated Category News Views 133

Strong Start to 2026 for Aehr Test Systems For shares of Aehr Test Systems, the year 2026 has kicked off in a remarkable way. As of the latest market close, the stock has risen by 44%, showcasing significant investor enthusiasm. This surge follows a recent earnings release that, while presenting mixed signals, ultimately contributed to a 16% jump in the stock price the...

Continue Reading
Carlton Precious Enhances Community Relations and Expansion Plans

Updated Category News Views 151

Carlton Precious Inc. Strengthens Community Engagement TORONTO — Carlton Precious Inc. (TSX-V: CPI | OTCQB: NBRFF), a notable player in precious and base metals exploration, is excited to share significant developments regarding its Esquilache Silver project. The Company has successfully finalized an agreement with the local community of San Antonio de Esquilache, which...

Continue Reading